Clinical Trial

A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.

Name: A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer. — clinical trial record (NCT07263178)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to comprehensively identify the various treatment patterns of second- or subsequent-line palliative chemotherapy used in patients with metastatic colorectal cancer who have experienced failure of first-line palliative chemotherapy and to evaluate the prognosis of each treatment.

Trial Details

NCT Number	NCT07263178
Lead Sponsor	Boryung Pharmaceutical Co., Ltd
Conditions	Metastatic Colorectal Cancer
Enrollment	1,000 participants
Start Date	2025-11-07
Primary Completion	2029-12 (estimated)
Study Completion	2029-12 (estimated)
Updated on ClinicalTrials.gov	2025-12-04